ACM
SQZ

ACT Capital Management’s SQZ Biotechnologies Company SQZ Stock Holding History

ACT Capital Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$36K Hold
16,000
– – 0.05% 61
2022
Q2 		$51K Hold
16,000
– – 0.07% 63
2022
Q1 		$77K Hold
16,000
– – 0.08% 70
2021
Q4 		$143K Sell
16,000
-6,000
-27% -$73.5K 0.1% 77
2021
Q3 		$317K Buy
22,000
+14,500
+193% +$197K 0.16% 70
2021
Q2 		$109K Buy
+7,500
New +$98K 0.06% 97

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACT Capital Management's SQZ Position: Q3 2022 in Review

ACT Capital Management held its SQZ Biotechnologies Company (SQZ) position steady in Q3 2022 at 16,000 shares worth $36K. The position accounts for 0.05% of the portfolio, ranked #61.

ACT Capital Management first reported a position in SQZ in Q2 2021 and has held it in 6 quarters since. The position peaked at $317K in Q3 2021. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • ACT Capital Management held 16,000 shares of SQZ Biotechnologies Company worth $36K as of Q3 2022.
  • ACT Capital Management left its SQZ Biotechnologies Company share count unchanged in Q3 2022.
  • SQZ Biotechnologies Company made up 0.05% of ACT Capital Management's portfolio in Q3 2022, its #61 holding.
  • ACT Capital Management first reported a position in SQZ Biotechnologies Company in Q2 2021 and has held it in 6 quarters since.
  • ACT Capital Management's SQZ Biotechnologies Company position peaked at $317K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.